Teligent, Inc. Announces FDA Approval of Gentamicin Sulfate Cream USP, 0.1% (Gentamicin Base)
Teligent, Inc. (TLGT)
Last teligent, inc. earnings: 11/4 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
teligent.investorroom.com
Company Research
Source: GlobeNewswire
BUENA, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Gentamicin Sulfate Cream USP, 0.1% (gentamicin base). This is Teligent’s fifth approval of 2019, and its thirty-seventh approval from its internally-developed pipeline of topical generic pharmaceutical medicines. Based on recent IQVIA data from October 2019, the total addressable market for this product is approximately $15.6 million. “This latest approval further demonstrates Teligent’s commitment to research and development and our ability to bring these drugs to market successfully,’’ commented Jason Grenfell-Gardner, President and CEO of the Company. “We plan to launch this product in November of 2019.” Mr. Grenfell-Gardner continued, “We now have forty-one topical generic pharmaceutical pro
Show less
Read more
Impact Snapshot
Event Time:
TLGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLGT alerts
High impacting Teligent, Inc. news events
Weekly update
A roundup of the hottest topics